Arkema invests 4 million euros at its Mourenx facility in France
"We are leaders in the sulfonyl market with MSA, and we want to continue investing in order to remain competitive and maintain our position," explains Arnaud d'Aramon, Group President of Arkema's Thiochemicals Business Unit.
Arkema is also increasing by 50% its overall MSA capacity in Mourenx by taking full advantage of its competitive edge due to its full integration in sulfur, sulfur intermediates, chlorine and hydrochloric acid.
Organizations
Other news from the department manufacturing
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.